ROTEM ERAN enters COLLPLANT BIOTECHNOLOGIES LTD with 60K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001213900-26-030158
Officer· Deputy CEO and CFO
Since Mar 2026
60K
Baseline shares
100% direct
60K
Direct ownership
1 position
186.71K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Restricted Share Units
DirectShares owned60K
Total
60K direct60K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Restricted Share Units | 60K | Direct |
| Total | 60K | 60K direct |
Derivative Holdings4
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
45K
Shares owned
N/A
Exercise price
4.02
Expiration
—
Exercise window
—
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
80K
Shares owned
N/A
Exercise price
6.39
Expiration
—
Exercise window
—
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
9K
Shares owned
N/A
Exercise price
4.02
Expiration
—
Exercise window
—
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
52.71K
Shares owned
N/A
Exercise price
6.39
Expiration
—
Exercise window
—
Total
Underlying
186.71K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 4.02 | — | — | 45K | N/A |
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 6.39 | — | — | 80K | N/A |
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 4.02 | — | — | 9K | N/A |
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 6.39 | — | — | 52.71K | N/A |
| Total | 186.71K | 0.00 | ||||